Covid-19 Research

Review Article

Nameko Mushroom (Pholiota microspore), Hiratake Mushroom (Pleurotus ostreatus) and Shimeji Mushrooms (Lyophyllum shimeji): Bioactive Compounds as a Source of Various Biological Activities: A Review

Journal of Biomedical Research & Environmental Sciences article abstract with citation details, DOI, publication dates, subject areas, full text links, and references.

View DOI Submit Manuscript

Article Details

Publication record, authors, dates, abstract, and full text access.

Open Access
Article Type Review Article
Subject Biology Group
OCLC JBRES Record
Waill A Elkhateeb* and Ghoson Daba
Issue: Volume5-Issue3
Pages: 256-266
Received: 2024-02-25
Accepted: 2024-03-25
Published: 2024-03-28

Abstract

Mushrooms are substantial source of nutritional, medicinal compounds, and other benefits compounds still need to be worked out for their important applications. Mushrooms as higher Basidiomycetes and Ascomycetes contain secondary metabolites in their fruit bodies, cultured mycelium, and cultured broth. These secondary metabolites have been used in many sides of human activity for many years for maintaining long and healthy life. The genera Pholiota, Pleurotus and Lyophyllum are a group of edible mushrooms that are distributed all over the world. The studies on different species of these edible mushrooms have revealed their nutritional medicinal potentials. This review aims to present the importance of Pholiota microspore, Pleurotus ostreatus and Lyophyllum shimeji, as both food and medicine, and they offer new visions to researchers to develop new drugs and nutraceuticals.

FullText HTML FullText PDF DOI: 10.37871/jbres1890 Crossmark

Certificate of Publication

Certificate of Publication

Copyright

© 2024 Elkhateeb WA, et al. Distributed under Creative Commons CC-BY 4.0 Creative CommonsAttribution

How to cite this article

Elkhateeb WA, Daba G. Nameko Mushroom (Pholiota microspore), Hiratake Mushroom (Pleurotus ostreatus) and Shimeji Mushrooms (Lyophyllum shimeji): Bioactive Compounds as a Source of Various Biological Activities: A Review. J Biomed Res Environ Sci. 2024 Mar 28; 5(3): 256-266. doi: 10.37871/jbres1890, Article ID: JBRES1890, Available at: https://www.jelsciences.com/ articles/jbres1890.pdf

Subject area(s)

Biology

References

  1. Elkhateeb WA, Daba GM, Thomas PW, Wen TC. Medicinal mushrooms as a new source of natural therapeutic bioactive compounds. Egypt Pharmaceu Journal. 2019;18(2):88-101. doi: 10.4103/epj.epj_17_19.
  2. Elkhateeb WA, Daba GM, Elnahas M, Thomas P, Emam M. Metabolic profile and skin-related bioactivities of cerioporus squamosus hydromethanolic extract. Biodiversitas Journal Biological Div. 2020;21(10):4732-474. doi: 10.13057/biodiv/d211037.
  3. Elkhateeb WA, Daba, G. The endless nutritional and pharmaceutical benefits of the Himalayan gold, cordyceps; Current knowledge and prospective potentials. Biofarmasi Journal of Natural Product Biochemistry. 2020;18(2):70-77. doi: 10.13057/biofar/f180204.
  4. Elkhateeb WA, Daba GM. Termitomyces marvel medicinal mushroom having a unique life cycle. Open Access Journal of Pharmaceutical Research. 2020;4(1):1-4. doi: 10.23880/oajpr-16000197.
  5. Daba GM, Elkhateeb W, Eldien AN, Fadl E, Elhagrasi A, Fayad W, Wen TC. Therapeutic potentials of n-hexane extracts of the three medicinal mushrooms regarding their anti-colon cancer, antioxidant, and hypocholesterolemic capabilities. Biodiversitas Journal of Biological Diversity. 2020;21(6):1-10. doi: 10.13057/biodiv/d210615.
  6. Elkhateeb WA. What medicinal mushroom can do?. Chem Res J. 2020;5(1):106-118.
  7. Elkhateeb WA, Daba GM, Elmahdy EM, Thomas PW, Wen TC, Mohamed N. Antiviral potential of mushrooms in the light of their biological active compounds. ARC J Pharmac Sci. 2019;5:8-12.
  8. El-Hagrassi A, Daba G, Elkhateeb W, Ahmed E, El-Dein AN, Fayad W, Shaheen M, Shehata R, El-Manawaty M, Wen T. In vitro bioactive potential and chemical analysis of the n-hexane extract of the medicinal mushroom, cordyceps militaris. Malays J Microbiol. 2020;16(1)40-48. doi: 10.21161/mjm.190346.
  9. Elkhateeb WA, Daba GM, El-Dein AN, Sheir DH, Fayad W, Shaheen MN, Wen TC. Insights into the In-vitro hypocholesterolemic, antioxidant, antirotavirus, and anticolon cancer activities of the methanolic extracts of a japanese lichen, candelariella vitellina, and a japanese mushroom, ganoderma applanatum. Egyptian Pharmaceutical Journal. 2020;19(1):77-83. doi: 10.4103/epj.epj_56_19.
  10. Elkhateeb WA, Zaghlol GM, El-Garawani IM, Ahmed EF, Rateb ME, Abdel Moneim AE. Ganoderma applanatum secondary metabolites induced apoptosis through different pathways: In vivo and in vitro anticancer studies. Biomed Pharmacother. 2018 May;101:264-277. doi: 10.1016/j.biopha.2018.02.058. Epub 2018 Feb 27. PMID: 29494964.
  11. Elkhateeb WA, Elnahas MO, Thomas PW, Daba GM. To Heal or Not to Heal? Medicinal mushrooms wound healing capacities. ARC Journal of Pharmaceutical Sciences. 2019;5(4):28-35.‏ doi: 10.20431/2455-1538.0504004.
  12. Elkhateeb WA, Daba GM, Elnahas MO, Thomas PW. Anticoagulant capacities of some medicinal mushrooms. ARC J Pharma Sci. 2019;5:12-16.Elkhateeb W, Elnahas MO, Paul W, Daba GM. Fomes fomentarius and polyporus squamosus models of marvel medicinal mushrooms. Biomed Res Rev. 2020;3:119. doi: 10.31021/brr.20203119
  13. Elkhateeb WA, Daba GM. Mycotherapy of the good and the tasty medicinal mushrooms lentinus, pleurotus, and tremella.‏ Journal of Pharmaceutics and Pharmacology Research. 2021;4(3):1-6. doi: 10.31579/2693-7247/29.
  14. Elkhateeb WA, Daba GM. The fascinating bird’s nest mushroom, secondary metabolites and biological activities.‏ International Journal of Pharma Research and Health Sciences. 2021;9(1):3265-3269. doi: 10.21276/ijprhs.2021.01.01.
  15. Elkhateeb WA, Daba GM, Gaziea SM. The anti-nemic potential of mushroom against plant-parasitic nematodes. Open Access Journal of Microbiology & Biotechnology. 2021;6(1):1-6. doi: 10.23880/oajmb-16000186.
  16. Elkhateeb WA, Elnahas MO, Thomas PW and Daba GM. Trametes versicolor and dictyophora indusiata champions of medicinal mushrooms. Open Access Journal of Pharmaceutical Research. 2020;4(1):1-7. doi: 10.23880/oajpr-16000192.
  17. Elkhateeb WA, Daba G. The endless nutritional and pharmaceutical benefits of the himalayan gold, cordyceps; current knowledge and prospective potentials. Biofarmasi Journal of Natural Product Biochemistry. 2020;18(2): 1-10.
  18. Thomas PW, Elkhateeb WA, Daba GM. Chaga (Inonotus obliquus): A medical marvel but a conservation dilemma?. Sydowia. 2020;72:123-130. doi: 10.12905/0380.sydowia72-2020-0123.
  19. Thomas P, Elkhateeb WA, Daba GM. Industrial applications of truffles and truffle-like fungi. In Advances in Macrofungi. 1st ed. CRC Press; 2021. p.82-88. doi: 10.1201/9781003096818-8.
  20. Elkhateeb W, Thomas P, Elnahas M, Daba G. Hypogeous and Epigeous mushrooms in human health. In Advances in Macrofungi. 1st ed. CRC Press; 2021. p.7-19. doi: 10.1201/9781003191278-2.
  21. Elkhateeb W, Elnahas Sung TJ M, Daba G. Infrequent current and potential applications of mushrooms. 1st ed. CRC Press; 2021. p.70-81. Doi: 10.1201/9781003096818-7.
  22. Elkhateeb WA, El Ghwas D, Gundoju N, Somasekhar T, Akram M, Daba GM. Chicken of the woods laetiporus sulphureus and schizophyllum commune treasure of medicinal mushrooms. Open Access Journal of Microbiology & Biotechnology. 2021;6(3):1-7. doi: 10.23880/oajmb-16000201.
  23. Elkhateeb WA, Daba GM. Highlights on unique orange pore cap mushroom favolaschia sp. and beech orange mushroom cyttaria sp. and their biological activities. Open Access Journal of Pharmaceutical Research. 2021;5(3): 1-6. doi: 10.23880/oajpr-16000246.
  24. Elkhateeb WA, Daba GM. Highlights on the wood blue-leg mushroom clitocybe nuda and blue-milk mushroom lactarius indigo ecology and biological activities. Open Access Journal of Pharmaceutical Research. 2021;5(3):1-6. doi: 10.23880/oajpr-16000249.
  25. Elkhateeb WA, Daba GM. Highlights on the golden mushroom cantharellus cibarius and unique shaggy ink cap mushroom coprinus comatus and smoky bracket mushroom bjerkandera adusta ecology and biological activities. Open Access Journal of Mycology & Mycological Sciences. 2021;4(2):1-8. doi:10.23880/oajmms-16000143.
  26. Thomas PW, Elkhateeb WA, Daba G. Truffle and truffle-like fungi from continental Africa. Acta mycological. 2019;54(2):1-15.
  27. ALKolaibe AG, Elkhateeb WA, Elnahas MO, El-Manawaty M, Deng CY, Wen, TC, Daba GM. Wound Healing, Anti-pancreatic cancer, and α-amylase inhibitory potentials of the edible mushroom, metacordyceps neogunnii. Research Journal of Pharmacy and Technology. 2021;14(10):5249-5253. doi: 10.52711/0974-360X.2021.00914.
  28. Elkhateeb WA, Daba GM. The coral mushrooms ramaria and clavaria. Studies in Fungi. 2021;6(1):495-506.
  29. Elkhateeb WA, Daba GM. Medicinal mushroom: What shuld we know? International Journal of Pharmaceutical Chemistry and Analysis. 2022;9(1):1-19. doi: 10.18231/j.ijpca.2022.001.
  30. Elkhateeb WA, Daba GM. The wild non edible mushrooms, what should we know so far?.International Journal of Advanced Biochemistry Research. 2022;6(1):43-50. doi: 10.33545/26174693.2022.v6.i1a.83.
  31. Hapuarachchi KK, Elkhateeb WA, Karunarathna SC, Cheng CR, Bandara AR, Kakumyan P, Hyde KD, Daba GM, Wen TC. Current status of global Ganoderma cultivation, products, industry and market. Mycosphere. 2018;9(5):1025-1052.doi: 10.5943/mycosphere/9/5/6.
  32. Elkhateeb WA, Daba GM. Therapeutic values of ganoderma oregonense and ganoderma pfeifferi, mushrooms: A Review. Open Access Journal of Pharmaceutical Research. 2023;7(1):1-6. doi:10.23880/oajpr-16000276.
  33. Elkhateeb WA, Daba GM. Vitamin D enriched edible mushrooms: A review. Open Access Journal of Mycology & Mycological Sciences. 2023;6(1)1-6. doi: 10.23880/oajmms-16000170.
  34. Elkhateeb WA, Galappaththi MC, El-Ghwas DE, Daba G. The anti-diabetic potential of mushrooms: A review. Current Trends in Biotechnology and Pharmacy. 2023;17(4):1415-1424. doi:10.5530/ctbp.2023.4.77.
  35. Elkhateeb WA, El-Ghwas DE, Daba GM. Mushrooms and lichens the factory of important secondary metabolites. Journal of Biomedical Research and Environmental Sciences. 2023;4(6):1072-1082.‏ doi: 10.37871/jbres1770.
  36. Elkhateeb WA, El-Ghwas DE, Daba GM. Anti-Inflammatory agents from Mushrooms: A review. Open Access Journal of Pharmaceutical Research. 2023;7(1):1-7. doi: 10.23880/oajpr-16000278.
  37. Matsumoto T, Fukumasa-Nakai Y, Nagasawa E, Obatake Y. Phylogenetic position of pholiota nameko in the genus pholiota inferred from restriction analysis of ribosomal DNA. Mycoscience. 2003;44(3):197-202. doi:10.1007/s10267-003-0109-0.
  38. Hirao AS, Kumata A, Takagi T, Sasaki Y, Shigihara T, Kimura E, Kaneko S. Japanese "nameko" mushrooms (Pholiota microspora) produced via sawdust-based cultivation exhibit severe genetic bottleneck associated with a single founder. Mycoscience. 2022 May 31;63(3):79-87. doi: 10.47371/mycosci.2022.03.002. PMID: 37089630; PMCID: PMC10012341.
  39. Zhang X, Liu T, Wang X, Zhou L, Qi J, An S. Structural characterization, antioxidant activity and anti-inflammatory of the phosphorylated polysaccharide from Pholiota nameko. Front Nutr. 2022 Aug 31;9:976552. doi: 10.3389/fnut.2022.976552. PMID: 36118783; PMCID: PMC9471013.
  40. Sung TJ, Wang YY, Liu KL, Chou CH, Lai PS, Hsieh CW. Pholiota nameko Polysaccharides Promotes Cell Proliferation and Migration and Reduces ROS Content in H2O2-Induced L929 Cells. Antioxidants (Basel). 2020 Jan 10;9(1):65. doi: 10.3390/antiox9010065. PMID: 31936888; PMCID: PMC7022505.
  41. Li H, Lu X, Zhang S, Lu M, Liu H. Anti-inflammatory activity of polysaccharide from Pholiota nameko. Biochemistry (Mosc). 2008 Jun;73(6):669-75. doi: 10.1134/s0006297908060060. PMID: 18620532.
  42. Zhang Y, Liu Z, Ng TB, Chen Z, Qiao W, Liu F. Purification and characterization of a novel antitumor protein with antioxidant and deoxyribonuclease activity from edible mushroom Pholiota nameko. Biochimie. 2014 Apr;99:28-37. doi: 10.1016/j.biochi.2013.10.016. Epub 2013 Nov 1. PMID: 24189312.
  43. Zheng L, Zhai G, Zhang J, Wang L, Ma Z, Jia M, Jia L. Antihyperlipidemic and hepatoprotective activities of mycelia zinc polysaccharide from Pholiota nameko SW-02. Int J Biol Macromol. 2014 Sep;70:523-9. doi: 10.1016/j.ijbiomac.2014.07.037. Epub 2014 Jul 29. PMID: 25077837.
  44. Rodrigues D, Freitas AC, Sousa S, Amorim M, Vasconcelos MW, da Costa JP, Silva AM, Rocha-Santos TA, Duarte AC, Gomes AM. Chemical and structural characterization of Pholiota nameko extracts with biological properties. Food Chem. 2017 Feb 1;216:176-85. doi: 10.1016/j.foodchem.2016.08.030. Epub 2016 Aug 11. PMID: 27596407.
  45. Li H, Zhang M, Ma G. Hypolipidemic effect of the polysaccharide from Pholiota nameko. Nutrition. 2010 May;26(5):556-62. doi: 10.1016/j.nut.2009.06.009. Epub 2009 Oct 7. PMID: 19815391.
  46. Giavasis I. Bioactive fungal polysaccharides as potential functional ingredients in food and nutraceuticals. Curr Opin Biotechnol. 2014 Apr;26:162-73. doi: 10.1016/j.copbio.2014.01.010. Epub 2014 Feb 8. PMID: 24518400.
  47. Toshiyuki T, Haruhito S, Shinji Y, Masaaki W. Radical-scavenging activity of fruiting bodies of pholiota nameko cultivated under different conditions. Mushroom Science and Biotechnology. 2010;18(2):67-71. doi: 10.24465/msb.18.2_67.
  48. Zheng L, Liu M, Zhai GY, Ma Z, Wang LQ, Jia L. Antioxidant and anti-ageing activities of mycelia zinc polysaccharide from Pholiota nameko SW-03. J Sci Food Agric. 2015 Dec;95(15):3117-26. doi: 10.1002/jsfa.7048. Epub 2015 Jan 13. PMID: 25511755.
  49. Abreu H, Simas FF, Smiderle FR, Sovrani V, Dallazen JL, Maria-Ferreira D, Werner MF, Cordeiro LMC, Iacomini M. Gelling functional property, anti-inflammatory and antinociceptive bioactivities of β-D-glucan from the edible mushroom Pholiota nameko. Int J Biol Macromol. 2019 Feb 1;122:1128-1135. doi: 10.1016/j.ijbiomac.2018.09.062. Epub 2018 Sep 13. PMID: 30218731.
  50. Adebayo EA, Martinez-Carrera D. Oyster mushrooms (Pleurotus) are useful for utilizing lignocellulosic biomass. African Journal of Biotechnology. 2015;14(1):52-67.doi: 10.5897/AJB2014.14249.
  51. Patel Y, Naraian R, Singh VK. Medicinal properties of pleurotus species (Oyster mushroom): A review. World Journal of Fungal and Plant Biology. 2012;3(1):1-12.
  52. Wasser SP. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol. 2002 Nov;60(3):258-74. doi: 10.1007/s00253-002-1076-7. Epub 2002 Sep 10. PMID: 12436306.
  53. Waktola G, Temesgen T. Pharmacological activities of Oyster mushroom (Pleurotus ostreatus). Novel Research in Microbiology Journal. 2020;4(2):688-695. doi: 10.21608/nrmj.2020.84017.
  54. Vieira PA, Gontijo DC, Vieira BC, Fontes EA, de Assunção LS, Leite JP, Kasuya MC. Antioxidant activities, total phenolics and metal contents in pleurotus ostreatus mushrooms enriched with iron, zinc or lithium. LWT-Food Science and Technology. 2013;54(2):421-425. doi: 10.1016/j.lwt.2013.06.016.
  55. Piska K, Sułkowska-Ziaja K, Muszyńska, B. Edible mushroom pleurotus ostreatus (oyster mushroom)-its dietary significance and biological activity. Acta Scientiarum Polonorum. Hortorum Cultus. 2017;16(1):151-161.
  56. Dos Reis EE, Schenkel PC, Camassola M. Effects of bioactive compounds from Pleurotus mushrooms on COVID-19 risk factors associated with the cardiovascular system. J Integr Med. 2022 Sep;20(5):385-395. doi: 10.1016/j.joim.2022.07.002. Epub 2022 Jul 11. PMID: 35879221; PMCID: PMC9271422.
  57. Abidin MH, Abdullah N, Abidin NZ. Therapeutic properties of pleurotus species (Oyster mushrooms) for atherosclerosis: A review. International Journal of Food Properties. 2017;20(6):1251-1261. doi: 10.1080/10942912.2016.1210162.
  58. Visnovsky SB, Cummings N, Guerin-Laguette A, Wang Y, Yamada A, Kobayashi H, Kawai M, Pitman AR. Detection of the edible ectomycorrhizal fungus Lyophyllum shimeji colonising seedlings of cultivated conifer species in New Zealand. Mycorrhiza. 2014 Aug;24(6):453-63. doi: 10.1007/s00572-013-0552-5. Epub 2014 Jan 21. PMID: 24445577.
  59. Ohta A. Production of fruit-bodies of a mycorrhizal fungus, Lyophyllum shimeji, in pure culture. Mycoscience. 1994;35(2):147-151. doi: 10.1007/BF02318492.
  60. Krupodorova TA, Barshteyn VY, Zabeida EF, Pokas EV. Antibacterial activity of macromycetes mycelia and culture liquid. Microbiology and Biotechnology Letters. 2016;44(3):246-253. doi: 10.4014/mbl.1603.03003.
  61. Russians N, Nur A, Mayawatie B, Andayaningsih, P. Cytotoxicity assay of ethyl acetate extract shimeji (Lyophyllum shimeji (Kawam.) Hongo) and white oyster mushroom (Pleurotus ostreatus Jacq.) against HCT-116 cell line. IOP Conference Series Earth and Environmental Science. 2018;197(1):012007. doi: 10.1088/1755-1315/197/1/012007.
  62. Lam SK, Ng TB. First simultaneous isolation of a ribosome inactivating protein and an antifungal protein from a mushroom (Lyophyllum shimeji) together with evidence for synergism of their antifungal effects. Arch Biochem Biophys. 2001 Sep 15;393(2):271-80. doi: 10.1006/abbi.2001.2506. PMID: 11556814.
  63. Badalyan SM, Zambonelli A. Biotechnological exploitation of macrofungi for the production of food, pharmaceuticals and cosmeceuticals. Advances in Macrofungi. 1st ed. CRC Press; 2019. p.199-230.
  64. Jung JW, Moon SM, Park BR, Kim SG, Kim JS, Kim CS. Anti-cancer activity of the protein extract from Lyophyllum shimeji in KB human oral squamous cell carcinoma. Oral Biology Research. 2014;38(2):99-105. doi: 10.21851/obr.38.2.201410.99.
Publish with JBRES — Peer-reviewed, multidisciplinary Open Access with rapid review, DOI, and global visibility.
Double-Blind CrossRef DOI Discoverable
Submit Manuscript Membership